SOLVAY 1220 (Creon 20 66,400 units amylase; 20,000 units lipase; 75,000 units protease)
Generic Name: pancrelipase
Pill imprint SOLVAY 1220 has been identified as Creon 20 66,400 units amylase; 20,000 units lipase; 75,000 units protease.
Creon is used in the treatment of chronic pancreatitis; pancreatic exocrine dysfunction; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Creon 66,400 units amylase; 20,000 units lipase; 75,000 units protease is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- 66,400 units amylase; 20,000 units lipase; 75,000 units protease
- Orange / Clear
- Rx and/or OTC
|NDC Code||Manufacturer / Repackager|
|54868-3475||Physicians Total Care Inc (repackager)|
Note: Inactive ingredients may vary.
More about Creon (pancrelipase)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.